Modulating the endocannabinoid system in human health and disease - successes and failures
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulating the endocannabinoid system in human health and disease - successes and failures
Authors
Keywords
-
Journal
FEBS Journal
Volume 280, Issue 9, Pages 1918-1943
Publisher
Wiley
Online
2013-04-04
DOI
10.1111/febs.12260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Effects of Chronic Cannabis Smoking
- (2013) R. Muniyappa et al. DIABETES CARE
- Metabolism of endocannabinoids and relatedN-acylethanolamines: Canonical and alternative pathways
- (2013) Natsuo Ueda et al. FEBS Journal
- Transport of endocannabinoids across the plasma membrane and within the cell
- (2013) Christopher J. Fowler FEBS Journal
- Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice
- (2013) Zongxian Cao et al. GASTROENTEROLOGY
- “Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
- (2012) Fabiana Piscitelli et al. ACS Chemical Neuroscience
- Marijuana use and long-term mortality among survivors of acute myocardial infarction
- (2012) Lauren Frost et al. AMERICAN HEART JOURNAL
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Fatty Acid Amide Hydrolase Deficiency Enhances Intraplaque Neutrophil Recruitment in Atherosclerotic Mice
- (2012) Sébastien Lenglet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch
- (2012) Jonas Kleyer et al. BIOCHEMICAL PHARMACOLOGY
- Rat and human fatty acid amide hydrolases: Overt similarities and hidden differences
- (2012) Almerinda Di Venere et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans
- (2012) Linda E. Klumpers et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
- (2012) Sabine Steffens et al. BRITISH JOURNAL OF PHARMACOLOGY
- Monoacylglycerol lipase - a target for drug development?
- (2012) CJ Fowler BRITISH JOURNAL OF PHARMACOLOGY
- Different Expression and Function of the Endocannabinoid System in Human Epicardial Adipose Tissue in Relation to Heart Disease
- (2012) Giuseppe Cappellano et al. CANADIAN JOURNAL OF CARDIOLOGY
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Cannabinoids and Atherosclerotic Coronary Heart Disease
- (2012) Sandeep Singla et al. CLINICAL CARDIOLOGY
- The Endocannabinoid System and Pain
- (2012) Josee Guindon et al. CNS & Neurological Disorders-Drug Targets
- Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
- (2012) Tiziana Bisogno et al. CNS & Neurological Disorders-Drug Targets
- Treatment of Cannabis Use Among People with Psychotic Disorders: A Critical Review of Randomised Controlled Trials
- (2012) Amanda L. Baker et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
- (2012) M. Rajesh et al. DIABETES
- β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner
- (2012) Béla Horváth et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
- (2012) Jie Liu et al. GASTROENTEROLOGY
- Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers
- (2012) David A. Gorelick et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1Receptors
- (2012) Mark Bauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic potential of monoacylglycerol lipase inhibitors
- (2012) Melinda M. Mulvihill et al. LIFE SCIENCES
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
- (2012) O Gunduz-Cinar et al. MOLECULAR PSYCHIATRY
- DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses
- (2012) Ku-Lung Hsu et al. Nature Chemical Biology
- Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain
- (2012) Bernard P. Roques et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all
- (2012) Vincenzo Di Marzo PAIN
- An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
- (2012) John P. Huggins et al. PAIN
- Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic–ischemic brain injury in rats
- (2012) Silvia Carloni et al. PEDIATRIC RESEARCH
- Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
- (2012) R. G. Pertwee PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Endocannabinoids in nervous system health and disease: the big picture in a nutshell
- (2012) S. D. Skaper et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Discovery of Prostamide F2α and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability
- (2012) Luisa Gatta et al. PLoS One
- Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor
- (2012) F. A. Pamplona et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism
- (2012) W. H. Brown et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anandamide uptake explained?
- (2012) Christopher J. Fowler TRENDS IN PHARMACOLOGICAL SCIENCES
- At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction
- (2012) Fabrizio Montecucco et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Coronary Vasomotor Control in Obesity and Morbid Obesity
- (2012) Alessandra Quercioli et al. JACC-Cardiovascular Imaging
- Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III
- (2012) Tripathi B Rajavashisth et al. BMJ Open
- A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease
- (2012) Justin R. Piro et al. Cell Reports
- The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
- (2011) Béla Horváth et al. AMERICAN JOURNAL OF PATHOLOGY
- Cannabis et infarctus du myocarde du sujet jeune : association fortuite ? À propos d’une observation
- (2011) A. Leblanc et al. ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE
- Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects
- (2011) Gai Ling Li et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The case for peripheral CB1receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
- (2011) George Kunos et al. BRITISH JOURNAL OF PHARMACOLOGY
- The endocannabinoid system and cancer: therapeutic implication
- (2011) Josée Guindon et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats
- (2011) Martin A Sticht et al. BRITISH JOURNAL OF PHARMACOLOGY
- Toxic Effects of Marijuana on the Cardiovascular System
- (2011) Balaji Pratap et al. Cardiovascular Toxicology
- Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
- (2011) Carol A. Rouzer et al. CHEMICAL REVIEWS
- Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
- (2011) F. Barutta et al. DIABETES
- The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques
- (2011) Fabrizio Montecucco et al. EUROPEAN HEART JOURNAL
- Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity
- (2011) A. Quercioli et al. EUROPEAN HEART JOURNAL
- Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
- (2011) Christian Ndong et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fatty Acid-binding Proteins TransportN-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors
- (2011) Martin Kaczocha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
- (2011) K. Ahn et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A catalytically silent FAAH-1 variant drives anandamide transport in neurons
- (2011) Jin Fu et al. NATURE NEUROSCIENCE
- Spinal anandamide produces analgesia in neuropathic rats: Possible CB1- and TRPV1-mediated mechanisms
- (2011) K. Starowicz et al. NEUROPHARMACOLOGY
- Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence
- (2011) C.J. Hillard et al. NEUROSCIENCE
- Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
- (2011) A. Mir et al. PEDIATRICS
- The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications
- (2011) L. K. Miller et al. PHARMACOLOGICAL REVIEWS
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
- (2011) D. K. Nomura et al. SCIENCE
- Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus
- (2010) Patricia E. Molina et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women
- (2010) Marie Therese Cooney et al. AMERICAN HEART JOURNAL
- Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol
- (2010) Natsuo Ueda et al. BIOFACTORS
- Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells
- (2010) Mohanraj Rajesh et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB1cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model
- (2010) Partha Mukhopadhyay et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2: a cannabinoid receptor with an identity crisis
- (2010) Brady K Atwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
- (2010) MS García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulation of nausea and vomiting by cannabinoids
- (2010) Linda A Parker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects
- (2010) Grzegorz Godlewski et al. CHEMISTRY & BIOLOGY
- Novel Natural and Synthetic Ligands of the Endocannabinoid System
- (2010) Lumir Hanus et al. CURRENT MEDICINAL CHEMISTRY
- Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs
- (2010) V. Marzo et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the Endocannabinoid System for the Treatment of Cancer – A Practical View
- (2010) Christopher J. Fowler et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
- (2010) F. Barutta et al. DIABETES
- Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
- (2010) J. Agudo et al. DIABETOLOGIA
- The Levels of the Endocannabinoid Receptor CB2and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma
- (2010) Maurizio Guida et al. ENDOCRINOLOGY
- Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?
- (2010) Christopher J. Fowler et al. EXPERIMENTAL NEUROLOGY
- Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
- (2010) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
- (2010) Nephi Stella GLIA
- Endocannabinoids in liver disease
- (2010) Joseph Tam et al. HEPATOLOGY
- Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells
- (2010) J.C. Lim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients
- (2010) Giovanni Annuzzi et al. Lipids in Health and Disease
- Possible Anandamide and Palmitoylethanolamide involvement in human stroke
- (2010) Marcello Naccarato et al. Lipids in Health and Disease
- Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
- (2010) Jason R Clapper et al. NATURE NEUROSCIENCE
- Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
- (2010) Joel E Schlosburg et al. NATURE NEUROSCIENCE
- Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis
- (2010) C. Petrella et al. NEUROGASTROENTEROLOGY AND MOTILITY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Cannabinoids and the gut: New developments and emerging concepts
- (2010) Angelo A. Izzo et al. PHARMACOLOGY & THERAPEUTICS
- The Effects of Cannabis on Heart Rate Variability and Well-Being in Young Men
- (2010) K. Schmid et al. PHARMACOPSYCHIATRY
- Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors
- (2010) Maria Teresa Cencioni et al. PLoS One
- N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)
- (2010) Natsuo Ueda et al. PROGRESS IN LIPID RESEARCH
- THE EFFECTS OF THE CANNABINOID CB2 RECEPTOR ANTAGONIST, AM630, ON ISOLATION REARING-INDUCED BEHAVIOURAL DEFICITS IN RATS
- (2010) Asma Khan et al. SCHIZOPHRENIA RESEARCH
- Cannabinoids and the skeleton: From marijuana to reversal of bone loss
- (2009) Itai Bab et al. ANNALS OF MEDICINE
- Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression
- (2009) Emmanuel S. Onaivi et al. Annals of the New York Academy of Sciences
- Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis
- (2009) Fabrizio Montecucco et al. ATHEROSCLEROSIS
- Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance
- (2009) Francesca Borrelli et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
- (2009) Rosa María Tolón et al. BRAIN RESEARCH
- The endocannabinoid system as a target for the treatment of motor dysfunction
- (2009) Javier Fernández-Ruiz BRITISH JOURNAL OF PHARMACOLOGY
- CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
- (2009) Partha Mukhopadhyay et al. CARDIOVASCULAR RESEARCH
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
- (2009) Daniel K. Nomura et al. CELL
- Effect of Rimonabant on Glycemic Control in Insulin-Treated Type 2 Diabetes: The ARPEGGIO Trial
- (2009) P. A. Hollander et al. DIABETES CARE
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy
- (2009) Nicole Defer et al. FASEB JOURNAL
- Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
- (2009) Sasidhar Murikinati et al. FASEB JOURNAL
- Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
- (2009) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
- (2009) Onintza Sagredo et al. GLIA
- Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
- (2009) Martin A. Storr et al. INFLAMMATORY BOWEL DISEASES
- FAAH deficiency promotes energy storage and enhances the motivation for food
- (2009) C Touriño et al. INTERNATIONAL JOURNAL OF OBESITY
- Cannabinoid Receptor-1 Blockade Attenuates Acute pancreatitis in Obesity by An adiponectin Mediated Mechanism
- (2009) Nicholas J. Zyromski et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis
- (2009) J. Tschop et al. JOURNAL OF IMMUNOLOGY
- CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
- (2009) Fabrizio Montecucco et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner
- (2009) Irene Amorós et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure
- (2009) Florian Weis et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
- (2009) M. T. Viscomi et al. JOURNAL OF NEUROSCIENCE
- F2-Isoprostanes and 2-Arachidonylglycerol as Biomarkers of Lipid Peroxidation in Pigs with Hepatic Ischemia/Reperfusion Injury
- (2009) Yuji Ishii et al. JOURNAL OF SURGICAL RESEARCH
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury
- (2009) Ming Zhang et al. MICROVASCULAR RESEARCH
- Cannabinoid Type 2 Receptor as a Target for Chronic - Pain
- (2009) Massimiliano Beltramo MINI-REVIEWS IN MEDICINAL CHEMISTRY
- CB1 antagonists for obesity—what lessons have we learned from rimonabant?
- (2009) Vincenzo Di Marzo et al. Nature Reviews Endocrinology
- An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis
- (2009) F. Loría et al. NEUROBIOLOGY OF DISEASE
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833
- (2009) Bing Hu et al. PAIN
- Endocannabinoids and cardiac contractile function: Pathophysiological implications
- (2009) Sándor Bátkai et al. PHARMACOLOGICAL RESEARCH
- Cannabinoids in intestinal inflammation and cancer
- (2009) Angelo A. Izzo et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoid system modulation in cancer biology and therapy
- (2009) Simona Pisanti et al. PHARMACOLOGICAL RESEARCH
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis
- (2009) Balázs Csóka et al. PLoS One
- Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
- (2009) Lucia Marquéz et al. PLoS One
- Endocannabinoids: Friends and foes of reproduction
- (2009) Mauro Maccarrone PROGRESS IN LIPID RESEARCH
- The emerging role of the endocannabinoid system in cardiovascular disease
- (2009) Pál Pacher et al. Seminars in Immunopathology
- The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
- (2009) Tamás Bíró et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- An exploratory prospective study of marijuana use and mortality following acute myocardial infarction
- (2008) Kenneth J. Mukamal et al. AMERICAN HEART JOURNAL
- Endocannabinoids and Liver Disease. V. Endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis
- (2008) Leila Moezi et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
- (2008) Marnie Duncan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
- (2008) Fabrizio Montecucco et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases
- (2008) Pál Pacher et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice
- (2008) Frédérique Dol-Gleizes et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
- (2008) Praveen Anand et al. BRAIN RESEARCH REVIEWS
- The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development
- (2008) D. Zheng et al. CANCER RESEARCH
- Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages
- (2008) Koichi Sugamura et al. CIRCULATION
- Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
- (2008) Cecilia Hillard CURRENT PHARMACEUTICAL DESIGN
- SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients: Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
- (2008) J. Rosenstock et al. DIABETES CARE
- The endocannabinoid system in obesity and type 2 diabetes
- (2008) V. Di Marzo DIABETOLOGIA
- Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia
- (2008) Kirsten R Müller-Vahl et al. Expert Review of Neurotherapeutics
- Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
- (2008) A A Izzo et al. GUT
- Modulation of the Endocannabinoid System in Cardiovascular Disease
- (2008) Pál Pacher et al. HYPERTENSION
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoids and the Control of Energy Homeostasis
- (2008) George Kunos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain
- (2008) Gabriel M. Simon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The CB2Cannabinoid Receptor Controls Myeloid Progenitor Trafficking
- (2008) Javier Palazuelos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
- (2008) Martin A. Storr et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The Role of the Endocannabinoid System in Atherosclerosis
- (2008) F. Mach et al. JOURNAL OF NEUROENDOCRINOLOGY
- Endocannabinoids and the Regulation of Bone Metabolism
- (2008) I. Bab et al. JOURNAL OF NEUROENDOCRINOLOGY
- Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
- (2008) E. J. Rahn et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
- (2008) Lumír Ondřej Hanuš MEDICINAL RESEARCH REVIEWS
- A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules
- (2008) L. Mestre et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Targeting the endocannabinoid system: to enhance or reduce?
- (2008) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain
- (2008) M. Palkovits et al. NEUROSCIENCE
- Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury
- (2008) M. Zhang et al. NEUROSCIENCE
- Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
- (2008) Christoph W. Michalski et al. PLoS One
- Biology of endocannabinoid synthesis system
- (2008) Jun Wang et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
- (2008) George Kunos et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
- (2008) Denise Richardson et al. ARTHRITIS RESEARCH & THERAPY
- Play an ADAGIO with a STRADIVARIUS: the right patient for CB1 receptor antagonists?
- (2008) Vincenzo Di Marzo Nature clinical practice. Cardiovascular medicine
- Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis
- (2007) Sören V. Siegmund et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
- (2007) A. Mallat et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- CB2 receptors as new therapeutic targets for liver diseases
- (2007) S Lotersztajn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
- (2007) J Guindon et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration
- (2007) M Rajesh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning
- (2007) P Pacher et al. BRITISH JOURNAL OF PHARMACOLOGY
- The peripheral cannabinoid receptor knockout mice: an update
- (2007) N E Buckley BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid receptors and the regulation of bone mass
- (2007) I Bab et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2receptors in the brain: role in central immune function
- (2007) G A Cabral et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2receptor-mediated migration of immune cells: it can go either way
- (2007) A M Miller et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- (2007) K L Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2receptors in human brain inflammation
- (2007) C Benito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids in pancreatic cancer: Correlation with survival and pain
- (2007) Christoph W. Michalski et al. INTERNATIONAL JOURNAL OF CANCER
- Multiple pathways involved in the biosynthesis of anandamide
- (2007) Jie Liu et al. NEUROPHARMACOLOGY
- Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions
- (2007) Z. De March et al. NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search